流动性告急。 作者/方圆 没有最热，只有更热。 新年伊始，港股I PO火爆开局：短短两个月，港股新股募资金额已超8 9 2亿港元，是去年同期的1 0倍。眼前，港交所还有超4 8 0家企业 在排队上市，队伍浩浩荡荡。 此番景象，是2 0 2 5年赴港上市潮的延续——11 9家企业接连登台，港交所重回全球交易所I PO募资额榜首。新股赚钱效应强劲，投资 人争夺锚定份额、超额认购万倍的市场消息此起彼伏，首日暴涨、创业上岸的财富故事不绝于耳。 然而，一边是千亿I PO募资，一边却是万亿限售股待解禁。更现实的问题是，眼下港股的日均交易额在2 5 0 0亿港元上下徘徊，却有过 半数公司日成交额不足一百万港币——公司上市了，也没人买。 听闻多家投资机构的老大在春节后的开工会上下发"硬任务"——抓紧推企业赴港I PO。"港股能撑得住吗？"投资人开始隐隐担忧。水 面之下，暗流涌动。 2025，赴港上市潮 难掩尴尬一幕 2 0 2 5年7月9日，港交所交易大厅里五家公司——蓝思科技、极智嘉、峰岹科技、讯众通信、大众口腔同时I PO挂牌上市。到了年末， 英矽智能、五一视界、迅策、美联股份、卧安机器人与林清轩又上演"六锣齐鸣"。 正 ...

Group 1 - The core viewpoint of the report is that the current wave of IPOs in the Hong Kong market is unlikely to cause significant liquidity concerns, despite the anticipated influx of listings in 2026 [1][4] - The report highlights that the number of IPOs in 2025 reached 117, raising a total of 286.33 billion HKD, which is a year-on-year increase of 224.8% [1][11] - The report indicates that the refinancing scale also increased to 326.37 billion HKD, marking a year-on-year growth of 272.9% [1][11] Group 2 - The report discusses that historically, the impact of IPOs and refinancing on the market is often felt in the medium term, particularly when financing exceeds 10 billion HKD, which can lead to market downturns [2][15] - It notes that large IPOs exceeding 15 billion HKD can boost short-term market sentiment, while refinancing tends to have a more immediate negative impact on market performance [2][19] - The report emphasizes that the market is more sensitive to refinancing than to IPOs, with significant refinancing amounts being better absorbed during bullish market conditions [2][24] Group 3 - The report suggests that the current macroeconomic environment, characterized by weak economic growth and high interest rates, can amplify market pressures [3][39] - It identifies that the current IPO wave is led by technology and manufacturing sectors, with a significant portion of the funds raised coming from AH shares, which is a notable shift from previous IPO trends dominated by Chinese concept stocks [3][11] - The report also highlights that the market response to new listings has been more positive, with new stocks receiving a premium compared to the broader market [3][4] Group 4 - The report concludes that the liquidity risks in the Hong Kong market for 2026 are manageable, with the IPOs themselves not being the core issue [4][39] - It mentions that there are over 300 IPO applications currently pending, indicating a continued interest in the market [4][11] - The report also points out that while there may be concerns about a wave of lock-up expirations later in the year, the overall market environment remains supportive for IPO activities [4][39]

Group 1 - The core viewpoint of the articles indicates a significant inflow of southbound funds into the Hong Kong stock market, with a net inflow of 28.8 billion HKD on January 6 and a record high of 187.2 billion HKD on January 5, marking the highest single-day inflow in nearly two and a half months [1] - In 2025, the total net purchase of southbound funds reached 1.4 trillion HKD, representing a year-on-year growth of 73.89%, the highest since the launch of the Shanghai-Hong Kong Stock Connect in 2014 [1] - Xu Meng, head of the quantitative investment department at Huaxia Fund, predicts that 2026 will be a year of valuation contraction and profit growth for Hong Kong stocks, with continued inflows of southbound funds expected [1] Group 2 - The Hang Seng Technology Index ETF (513180.SH) serves as a benchmark for the Hong Kong technology sector, covering internet, hard technology, and new energy vehicle sectors [2] - The enhanced Hang Seng Technology ETF (159101.SZ) adds exposure to the biotechnology sector and increases the weight limit for individual constituent stocks to 15% [2] - The Hang Seng Internet ETF (513330.SH) focuses on software applications and internet media, with major companies like Alibaba, Tencent, and Meituan accounting for nearly 40% of its weight [2] - The Hang Seng Pharmaceutical ETF (159892.SZ) targets innovative drugs and leading CXO companies, currently characterized by low valuations and low crowding [2]

Group 1 - The article discusses the unique advantage of the Hong Kong stock market in welcoming new stock listings, providing global investors with investment options in RMB assets [3] - An increase in new stock listings may dilute liquidity in the Hong Kong market, posing a challenge, especially during periods of tight liquidity [3] - Recent trends show that the valuation of Hong Kong stocks has declined, with frequent occurrences of new stocks breaking below their issue price, which may suppress the pace of new stock issuance [3] Group 2 - Companies with strong cash flow and self-sustaining capabilities, such as high-dividend stocks in Hong Kong, tend to exhibit less volatility during bear markets [4] - High-dividend stocks are considered resilient during market downturns due to their cash flow, which supports reinvestment through dividends [4] - Leading technology companies in Hong Kong are likely to increase their share buyback activities when valuations are low, serving as a qualitative indicator of market valuation [4]

Core Viewpoint - The Hong Kong IPO market experienced a rare event where four new stocks collectively fell below their issue prices on their first trading day, indicating a significant shift in market sentiment and performance [2][3]. Group 1: IPO Performance - Four new stocks listed on December 22, 2025, including Mingji Hospital, Impression Dahongpao, Huazai Biotechnology, and Nanhua Futures, saw declines of 49.46%, 35.28%, 29.32%, and 24.17% respectively, with Mingji Hospital's drop marking the largest first-day decline for a new stock since 2025 [2][4]. - In December 2025, out of 17 newly listed stocks, 9 experienced first-day declines, representing over 50% of the total, contrasting sharply with the strong performance of new stocks earlier in the year [3]. Group 2: Market Conditions - The overall liquidity environment in the Hong Kong market has tightened, with daily trading volumes on the Hong Kong Stock Exchange falling below 2 billion HKD, and net inflows from southbound funds significantly decreasing to 219.12 billion RMB in December [5][6]. - The Hang Seng Index, Hang Seng Tech Index, and Hang Seng China Enterprises Index all experienced declines of 1.10%, 2.82%, and 1.96% respectively during the week of December 15-19, 2025 [5]. Group 3: Factors Influencing Performance - The recent decline in new stock performance is attributed to multiple factors, including tightening liquidity, high valuations relative to fundamental performance, and regulatory changes affecting public fund holdings in Hong Kong stocks [7][8]. - Mingji Hospital's high price-to-earnings (P/E) ratio of approximately 29.8 times compared to the average P/E of 17 times for the private hospital sector in Hong Kong indicates a mismatch between valuation and fundamental performance [8][9]. Group 4: Regulatory Changes - The introduction of "Mechanism B" for IPOs allows issuers to set a lower limit on the proportion of shares available for public subscription, which can reduce the risk of mispricing but may also limit the ability of companies with high valuations to attract sufficient demand [9][10]. - Mingji Hospital utilized Mechanism B for its IPO, issuing 67 million shares with only 10% allocated for public sale, resulting in a limited float of approximately 394 million HKD [10].

Core Viewpoint - The Hong Kong market has been underperforming since the fourth quarter, with significant declines in liquidity and trading volume, which are critical factors affecting market performance [1][2][3]. Liquidity Issues - The average daily trading volume in Hong Kong stocks fell to HKD 230.7 billion in November, a decrease of 16.1% month-on-month, and continued to decline in December, down approximately 13% [2]. - The reduction in southbound capital flow, foreign capital withdrawal, and ongoing IPO activities have collectively contributed to the liquidity downturn in the Hong Kong market [3][4]. - As of December 12, net inflows from southbound capital were HKD 7.906 billion, significantly lower than the monthly average of HKD 125.6 billion from January to November 2025 [4]. - Concerns among investors include foreign capital reducing positions before the Christmas holidays, hedge funds shorting due to economic uncertainties, and new regulations affecting fund investments [4]. Market Sentiment and External Factors - The liquidity issue is expected to continue to constrain the Hong Kong market, affecting overall valuation recovery and making the market more susceptible to external sentiment fluctuations [8]. - Key signals to watch for market recovery include a stable interest rate environment from the Federal Reserve and a verifiable recovery in domestic economic performance and corporate earnings [8]. Long-term Solutions for Liquidity - Addressing the liquidity challenges in the Hong Kong market requires a multi-faceted approach, including enhancing corporate earnings growth, improving market policies, and creating a favorable external environment [9][10]. - Specific recommendations include increasing the accessibility of southbound capital, encouraging foreign investment, and optimizing the IPO and delisting ecosystem to enhance liquidity for small-cap stocks [10][11]. - The market's liquidity is also tied to mainland economic policies, necessitating stable growth expectations to attract long-term capital [10].

Core Viewpoint - The recent performance of new stocks in the Hong Kong market has been notably poor, with four new listings experiencing significant declines on their first trading day, marking a rare occurrence of collective price drops among new stocks [1][2]. Group 1: New Stock Performance - Four new stocks listed on December 22, 2025, saw substantial declines: Ming Kee Hospital down 49.46%, Impression Da Hong Pao down 35.28%, Huazai Biotechnology down 29.32%, and Nanhua Futures down 24.17% [1][3]. - This trend of new stocks underperforming is not isolated; over half of the 17 new stocks listed in December 2025 have experienced price drops on their first day [2]. Group 2: Market Conditions - The overall liquidity environment in the Hong Kong market has tightened, with daily trading volumes falling below HKD 2 trillion, and southbound capital inflows significantly reduced [1][4]. - Southbound capital net inflows for December 2025 were only HKD 21.91 billion, a stark contrast to previous months where inflows often exceeded HKD 100 billion [5][6]. Group 3: Factors Influencing Performance - The decline in new stock performance is attributed to multiple factors, including tightening liquidity and high valuations not aligning with fundamental performance [1][7]. - Specific to Ming Kee Hospital, its price-to-earnings (PE) ratio was approximately 29.8 times, significantly higher than the average PE of 17 times for the private hospital sector in Hong Kong [8][10]. - The company's revenue for the first half of 2025 was reported at HKD 1.312 billion, a decline of 1.34% year-on-year, with net profit also decreasing by 23.18% [8]. Group 4: IPO Mechanisms - The introduction of "Mechanism B" for IPOs allows issuers to set a lower limit on the public offering portion, which can lead to smaller trading volumes and potentially lower the risk of price drops [9][10]. - However, this mechanism can also backfire for companies with high valuations and weak demand, as it lacks a mechanism to adjust allocations to retail investors [10].

Group 1 - Hong Kong's offshore financial market is closely linked to liquidity conditions [1] - In November, the average daily trading volume of Hong Kong stocks was HKD 230.7 billion, a decrease of approximately 16% compared to October [3] - Trading volume continued to decline in December, with a further month-on-month drop of about 13%, marking a nearly 40% decrease from the peak in September [3]

Group 1 - The Hong Kong stock market has experienced a significant decline in the fourth quarter, with the Hang Seng Index dropping from a high of 27,381.84 points on October 2 to a low of 25,086.54 points on December 16, indicating a weaker performance compared to US and A-shares [1] - The liquidity in the Hong Kong market has been continuously decreasing since late October, with the average daily net turnover in November being 230.7 billion HKD, a decrease of 16.1% compared to October [1] - In December, the average daily trading volume further declined by approximately 13% month-on-month, representing a 40% drop from the peak in September [1] Group 2 - Industry experts attribute the low liquidity in the Hong Kong stock market to several factors, including reduced activity from southbound funds, partial withdrawal of foreign capital, and ongoing challenges with IPOs draining liquidity [1] - As an offshore market, Hong Kong is particularly sensitive to liquidity changes, and addressing the liquidity issues will require a comprehensive approach focusing on incremental capital and market structure [1]

Core Viewpoint - The Hong Kong stock market has experienced a significant decline since the fourth quarter, with the Hang Seng Index dropping from a high of 27,381.84 points on October 2 to a low of 25,086.54 points on December 16, underperforming compared to US and A-shares [1] Group 1: Market Liquidity - The liquidity in the Hong Kong stock market has been decreasing since late October, with average daily trading volume falling to 230.7 billion HKD in November, a 16.1% decrease from October, and further declining by approximately 13% in December [1] - The reduction in southbound capital activity, foreign capital withdrawal, and ongoing IPOs are contributing factors to the low liquidity in the Hong Kong market [1][2] - As of December 12, net inflow of southbound capital was only 7.906 billion HKD for the month, significantly lower than the average monthly inflow of 125.6 billion HKD from January to November [2] Group 2: External Factors - Concerns regarding foreign capital behavior, such as profit-taking before the Christmas holiday and hedge funds shorting due to year-end uncertainties, are impacting market sentiment [2][3] - The overall trend shows that despite some net inflow through ETFs, foreign capital is exhibiting a high sell-low buy behavior, indicating risk aversion [3] Group 3: IPO Impact - The continuous increase in IPOs since May has created a liquidity "drain" effect, exacerbated by the expectation of 124.1 billion HKD in lock-up shares being released in December [3] - The market is facing pressure from both the influx of new listings and the release of previously locked shares, which could further strain liquidity [3] Group 4: Future Outlook - Short-term liquidity issues are expected to continue to constrain the Hong Kong market, affecting overall valuation recovery and making the market more susceptible to external emotional fluctuations [4] - Key signals to watch for market recovery include a clear and stable interest rate cut cycle from the Federal Reserve and a sustained recovery trend in corporate earnings [4] - Long-term prospects remain positive, with expectations that the Fed's rate cuts will enhance Hong Kong's attractiveness to global capital, particularly in sectors like raw materials, information technology, and healthcare [5] Group 5: Solutions for Liquidity Issues - Addressing the liquidity problem requires a multi-faceted approach, including shifting the focus from "liquidity speculation" to solid corporate earnings growth, improving policies and systems, and enhancing the external environment [6][7] - Specific recommendations include expanding the scope of southbound capital investments, optimizing the IPO and delisting ecosystem, and enhancing the trading environment for small-cap stocks [7][8] - Encouraging high dividend assets and attracting quality companies from Belt and Road Initiative countries for IPOs could also bolster market liquidity [8]